Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
16.94
+1.76 (11.63%)
Nov 9, 2026, 1:37 PM EST - Market open
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $248.58 million as of November 9, 2026. It is the 19,794th most valuable company in the world and the 3,456th biggest in the United States. Its market cap has increased by 107.18% in one year.
Market Cap
248.58M
Enterprise Value
239.70M
1-Year Change
107.18%
Global Rank
Country Rank
#3,456 United States
Category
ChartMarket Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $248.58M, an increase of 261.89%. That is a compound annual growth rate of 23.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 248.58M | -14.60% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evommune | 240.98M |
| Immuneering | 238.65M |
| Abeona Therapeutics | 238.46M |
| Lexeo Therapeutics | 235.87M |
| Vanda Pharmaceuticals | 230.09M |
| Cartesian Therapeutics | 229.34M |
| AC Immune | 222.72M |
| Korro Bio | 222.65M |